Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VEOZAH safely and effectively. See full prescribing information for VEOZAH. VEOZAH® (fezolinetant) tablets, for oral useInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
VEOZAH® is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
- generic_name
- fezolinetant
- product_names
- fezolinetant
- ndc
- 0469-2660, 0469-2460, 0469-2760, 0469-2660-30, 0469-2660-90, 0469-2460-07, 0469-2460-28, 0469-2760-07, 0469-2760-28
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en